NIPT Blood Test - Advanced

Service Description

NIPT is a safe and non-Invasive screening test that uses cell free DNA (cf DNA) found in maternal blood to detect chromosomal anomalies accurately, starting from WEEK 10 of pregnancy. What is Trisomy? Normally, all cells in the human body have 46 chromosomes, made up of 23 pairs of chromosomes. These 23 pairs of chromosomes contain all of the DNA to determine the health of the baby. Certain genetic anomalies can occur when a baby develops three copies of a particular chromosome instead of two. The risk of having a chromosomal condition increases as the mother gets older. For more details on the different Trisomy Chromosomes, please visit our website. What are Sex Chromosome Aneuploidies? Sex chromosome anomalies (SCA) occur when there is a missing, extra or partial/incomplete sex chromosome (X or Y). For more details on Sex Chromosome Aneuploidies, please visit our website. Why should I take the test? NIPT detects the possible anomalies at a very early stage, i.e., Week 10, with a high degree of accuracy and low false-positive rate. How does the test work? It involves a simple blood draw from the arm of the pregnant woman. The blood sample contains maternal and fetal DNA. Non-Invasive Pre-Natal tests can help identify if your baby is likely to have a chromosomal condition. Is it safe for mother and child? It involves a simple and safe blood draw from the arm of the expectant mother. Being non-invasive, it is completely safe for mother and baby. Why not just stick with the NHS Screening? The NHS provides combined screening to detect the risk of chromosomal abnormalities, but there are concerns over the accuracy and false positive rate: Accuracy is 85% for First Trimester Screening and 8-% for the Quadruple Screening Test. There is a 5% false positive rate leading to invasive further diagnostic testing (amniocentesis or CVS), which involves a risk to the pregnancy. NIPT is only offered for high-risk pregnancies identified by First Trimester screening or the Quadruple test.